Calycosin mitigates chondrocyte inflammation and apoptosis by inhibiting the PI3K/AKT and NF-κB pathways
- 1 October 2022
- journal article
- research article
- Published by Elsevier BV in Journal of Ethnopharmacology
- Vol. 297, 115536
- https://doi.org/10.1016/j.jep.2022.115536
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Regulation of NF-κB by TNF family cytokinesSeminars in Immunology, 2014
- Antineoplastic effect of calycosin on osteosarcoma through inducing apoptosis showing in vitro and in vivo investigationsExperimental and Molecular Pathology, 2014
- The epidemiology of osteoarthritisBest Practice & Research Clinical Rheumatology, 2014
- TNF-α and IL-1β Promote a Disintegrin-like and Metalloprotease with Thrombospondin Type I Motif-5-mediated Aggrecan Degradation through Syndecan-4 in Intervertebral Disc*Online Journal of Public Health Informatics, 2011
- Role of proinflammatory cytokines in the pathophysiology of osteoarthritisNature Reviews Rheumatology, 2010
- The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the mouseOsteoarthritis and Cartilage, 2010
- Regulation and Function of NF-κB Transcription Factors in the Immune SystemAnnual Review of Immunology, 2009
- The PI3K pathway regulates endochondral bone growth through control of hypertrophic chondrocyte differentiationBMC Developmental Biology, 2008
- Matrix Metalloproteinases: Role In ArthritisFrontiers in Bioscience-Landmark, 2006
- Interleukin-1β Induces Different Gene Expression of Stromelysin, Aggrecan and Tumor-Necrosis-Factor-Stimulated Gene 6 in Human Osteoarthritic Chondrocytes in vitroPathobiology, 2000